Hospitals are the Foremost Users of the Healthcare Equipment Rental

The total value of the healthcare equipment rental market was USD 59.1 billion in 2023, and it will power at a rate of 5.7% by the end of this decade, to touch USD 86.8 billion by 2030.

To learn more about this report: https://bit.ly/3vke2F9

The growth has a lot to do with the growing requirement for medical instruments and rising count of hospitals and clinics providing advanced care. Furthermore, the high rate of medical equipment and the tax reimbursements on renting it are contributing to the growth of the industry. The introduction of tech cutting-edge products, for example sling lifts, will power the healthcare equipment leasing actions further.

Durable medical equipment held a key share, of 35%, as it supports more and more use. The growing count of disabled and elderly individuals will power the requirement for mobility and other sorts of assistive instruments, which will contribute to the development of this category.

The homecare category will grow at a substantial rate in the years to come, credited to the thriving prevalence of numerous ailments, for example diabetes, which needs therapeutic devices, such as insulin pumps.

The increasing need for home healthcare devices and elderly care centers is among the most-significant drivers for the healthcare equipment rental market in this category. The category’s development is bolstered by the rising populace of the aging, which is particularly susceptible to diabetes and cardiac ailments.

North America is the leader of the pack, with USD 29.5 billion, in 2023. This is because of the high requirement for the cutting-edge products and the existence of numerous leasing service providers. Furthermore, the increasing device cost powers the spending on the acquisition of the state-of-the-art therapeutic apparatus, which can be resolved by renting the equipment.

Due to the growing demand for medical instruments all over the world, the demand for healthcare equipment rental is on the rise. This trend will continue in the years to come as well.

Read More

Accelerometer Medical Sensors Industry Will Advance at a 14.4% CAGR

The accelerometer medical sensors market was USD 4,111.5 million in 2023, which will rise to USD 10,442.9 million, advancing at a 14.4% compound annual growth rate, by 2030.

To learn more about this report: https://bit.ly/3tzwyc6

This growth is mainly driven by the rising need for nonstop monitoring of health; physiological sensors miniaturization; and enhanced functions, cost-effectiveness, and ease of operation of these devices.

Furthermore, this growth is also assisted by the surging populace with high disposable salaries, which suggests they can easily spend money on developed technologies.

The wearables category, on the basis of products, is the major contributor to the industry. This can be because it is employed for measuring different factors of health like blood pressure, heart rate, and carbon dioxide level. The measurement of such factors assists healthcare professionals as well as researchers in gaining responses and providing greater treatment.

The hospitals & clinics category, on the basis of end user, is the major contributor to the industry. This can be because of the speedy acceptance of developed technologies, easy treatment availability and affordability, the existence of experienced specialists in these healthcare facilities, and the large patient pool.

Furthermore, the existence of numerous hospitals and the rising healthcare spending in both developing and developed nations like China, the U.S., and the U.K., and various chronic illness-associated surgeries are conducted in hospitals, which boosts the expansion of this category.

The chronic illness & risk monitoring category, on the basis of application, is leading the accelerometer medical sensors market. This is primarily because of the rising occurrence of cancer, cardiovascular illnesses, and other illnesses. The key causes of these illnesses comprise smoking and tobacco consumption, unhealthy dietary habits, and obesity. 

Moreover, the wellness monitoring category will propel at the fastest compound annual growth rate in the years to come. This is primarily because of the monitoring or tracking of health care parameters in a digital setting using sensor-based devices, which assists in monitoring movement as well as intensity.

North America is the largest contributor to the industry, and it is likely to remain the largest, generating USD 1.8 billion in 2030. This can be mainly because of the well-established healthcare system, coupled with the high disposable salary in this continent.

APAC is likely to be a significant contributor to the industry in 2030. This will be mainly attributed to the increasing unhealthy lifestyle among people, the surging aging populace, the rising incidence of cardiovascular illnesses, and the growing acceptance of developed technologies.

It is because of the rise in awareness about health and fitness, the accelerometer medical sensors industry will continue to grow significantly in the years to come.

Read More

North America Is Dominating Pyrogen Test Market

Revenue of USD 1,406.4 million was generated in the global pyrogen test market for 2023, which is expected to grow at a compound annual growth rate of 7.3% over the period from 2024 to 2030 and reach USD 2,284.2 million. This growth of the market can be credited to the increasing acceptance of pyrogen testing within the biopharmaceutical sector.

To learn more about this report: https://bit.ly/3viQeS0

Furthermore, the rising development in the biotechnology and pharmaceutical industries along with the increasing count of new biologics research and introductions is projected to fuel the demand for these testing for making safe and better drugs.

Pyrogen testing is a vital step for each medication and therapeutics to make it safer and more effective. Surge in the count of cancer cases and hereditary illnesses, modified treatments attained benefits in the treatment of these diseases.

Tailored medicine has the benefit that it uses people’s hereditary profiles to aid in decision-making for the prevention, diagnosis, and treatment of illnesses. Therefore, patients and businesses are quickly accepting modified drugs. Furthermore, modified treatment-based methods to clinical and genomic features are becoming more popular among patients with cancer and immunologic sicknesses. Hence, the increasing need for modified drugs is one of the key reasons propelling the demand for pyrogen testing solutions.

In the North American region, the U.S. dominates the industry. This is mainly because of the existence of advanced healthcare infrastructure, augmented concentration on new drug growth, and the presence of key biotechnology and biopharmaceutical companies, like Pfizer Inc. and F. Hoffmann-La Roche AG, in the country.

Furthermore, Canada is also generating substantial revenue for the North American industry. This can be credited to the rising pharmaceutical and biotechnology sector, the rising awareness regarding the safety of medications, and the growing R&D activities in the country.

Read More

AI in Medical Diagnostics Market is Led by North America

The size of the AI in medical diagnostics market was 1,297.6 million in 2023, and it will power at a rate of 23.1% by the end of this decade, to touch USD 5,541.7 million by 2030. 

This has a lot to do with the growing initiatives of the government for the acceptance of AI-based tech, the increasing usage of AI solutions by radiologists to reduce workload, the obtainability of funds to initiate AI-based startups, the arrival of big data, and the growing count of cross-industry partnerships & alliances.

Software was the leading component category, with about USD 0.5 billion in 2023, and it will also be like this in the years to come. This is because of the growing need for AI solutions based on software in the medical diagnostics industry for delivering precise outcomes in a short time and the growing count of IT firms delivering the same. 

Apart from that, the increasing expansion of novel software and new AI algorithms, and the mounting applications of AI-based software in more than a few fields for example radiology, cardiology, ophthalmology, neurology, and gynecology, amongst others are fostering the industry growth.

The in-vivo diagnostic category had a major revenue share, of 60%, in 2023, because of the growing occurrence of infectious along with chronic ailments, and maternity problems throughout childbirth. 

Amongst the in-vivo diagnostic applications, the neurology category has the largest share, because of the compensations of AI in diagnosing numerous neurological conditions for example cancers and brain tumors. Furthermore, AI aids radiologists in interpreting medical images for fast and precise diagnosis, minimalizing noise in medical images, and producing superior images with lesser radiation doses.

In the future, the ultrasound category will have a considerable share of the AI in medical diagnostics market. This is due to the mounting demand for ultrasound imaging test processes to identify more than a few ailments and conditions, together with the high level of precision in ultrasound, which is attained through AI.

North America is the leader of the industry, with a share of 45% in 2023. This is because of the high research and development investments, the increasing acceptance of tech cutting-edge solutions, and the existence of global players and their efforts to crop up with innovative medical diagnostics techs, in the region.

It is because of the rising use of AI solutions by radiologists to reduce workloads all over the world, the demand for AI in medical diagnostics solutions is on the rise. This trend will continue in the years to come as well.

Read More

Semiconductors Chemicals Market Will Reach USD 28.3 Billion by 2030

The global market size of semiconductor chemicals was estimated to be USD 12.5 billion. billion by 2023, and it is expected to grow at a compound annual growth rate of by 2030, the rate of 12.5% over 2024 to 2030 should reach USD 28.3 billion.

This growth of the market can be credited to the increasing usage of electronic devices, such as smartphones, laptops, and IoT gadgets, which has, ultimately, propelled the making of semiconductors. This has generated a high demand for chemicals that are utilized in wafer fabrication procedures. Furthermore, the progressing semiconductor technologies, like complex designs, and the evolution to smaller nodes require the growth of new chemicals, in order to fulfill the needs for efficiency, miniaturization, and performance.

The APAC region holds a substantial position in the semiconductor chemicals industry, and the region is projected to reach a value of over USD 6.0 billion by 2030. This can be credited to the increasing automotive sector and the increasing output of semiconductors. Along with the growing semiconductor production, the increasing R&D in this area is a substantial driver. The industry is also rising due to the robust government aid for digitization and the existence of key companies. In APAC, China grips the foremost position, credited to the fast acceptance of progressive technologies.

The global semiconductor market is witnessing a major trend, driving substantial growth in the semiconductor chemicals market. This growth is attributed to the pivotal role of semiconductor chemicals in powering electronic devices like tablets, smartphones, and laptops.

The increasing demand for semiconductor chemicals is driven by the widespread adoption of modern technologies across various industries. These chemicals play a crucial role in manufacturing and advancing semiconductor components used in diverse sectors such as aerospace, automotive, and general manufacturing.

The conductivity and efficiency of semiconductors are determined by the dopants incorporated during production. Proper functioning of these devices requires processes like etching, cleaning, doping, polishing, servicing, and regular maintenance. There is a continuous effort to improve efficiency and functionality by employing new materials in wafer fabrication, with a significant emphasis on sustainability. These advancements align with the growing use of renewable energy, electric vehicles, the Internet of Things (IoT), and other environmentally friendly approaches to life.

The market for semiconductor chemicals is driven by the adoption of advanced digital technologies across industries.

Read More

Healthcare Analytical Testing Services Market To Grow Fastest in the APAC

The size of the healthcare analytical testing services market was USD 7,240.1 million in 2023, and it will power at a compound annual growth rate of 11.5% by the end of this decade, to touch  a value of USD 15,390.5 million by 2030. 

This growth has a lot to do with the growing count of subcontracting actions of analytical testing services by some pharma companies. Furthermore, the rising count of clinical trials that include analytical testing, the growing requirement for drugs and therapeutics, and the increasing importance on biosimilars are other factors pushing the growth of the industry.

The bioanalytical testing services category held a major revenue share, of around 25%, in 2023. This is due to the accessibility of extensive bioanalytical testing services for a wider range of drug types, such as small molecules, biologics, and vaccines, and several drug manufacturers are constantly working to produce more reliable healthcare analytical procedures that are accurate and efficient.

Furthermore, the higher requirement for the newest bioanalytical testing services is observed by contract producers. Apart from that, large firms are reviving their pipelines by investing in research and development departments, and because of the growing difficulty of these testing services, companies are compliant with the norms and rules levied on them. 

Therefore, these factors are powering the requirement for healthcare analytical testing services. Likewise, the molecule bioanalytical requirement is on the rise, owing to the growing investments in amino acid production-based molecules and biological drugs.

Furthermore, the use of cell-based assays in bioanalytical testing services is resulting in high requirements for this kind of service. These cell-based assays are widely employed in high-throughput screening due to their competence in offering valuable in-vivo biological info that thus bustles the drug discovery procedure.

North America is the leader of the healthcare analytical testing services market, with manufacturers providing testing instruments along with high-end pharma materials, tech progressions, and collaborations amongst industry players to advance cutting-edge healthcare solutions.

APAC will power at the fastest rate of 12% in the years to come. This growth has a lot to do with the increasing investments by foreign corporations for the development of cutting-edge facilities and associations to increase the reach of their products and services to diverse locations, and enhancements done by governing bodies for varying standards of assessment to line up with the international standards in the region.

It is because of the acceptance of novel techniques all over the world, that the demand for healthcare analytical testing services is on the rise. This trend will continue in the years to come as well.

Read More

Imaging Chemicals Market Will Touch USD 47.0 Billion in 2030

The imaging chemicals market was USD 31.7 billion in 2023, which will touch USD 47.0 billion, with a 5.8% compound annual growth rate, by 2030.

The growth of this industry is primarily because of the different uses of these chemicals like packaging, printing, textiles, and medical diagnostics.

The growing occurrence of brain disorders, cancer, and various other illnesses boosts the need for diagnostic imaging tests, including magnetic resonance imaging, computed tomography, and X-rays. 

Furthermore, the growing acceptance of digital printing, as it is quicker and more effective compared to traditional processes, is further boosting this category expansion. The acceptance of digital printing is also rising because of the shifting customer demands.

The printing & packaging category, based on application, was the largest contributor to the imaging chemicals market. This is because of the growing need for printing and packaging across the globe. Therefore, the surging need for the different chemicals utilized for this purpose makes the industry competitive.

Therefore, the growing occurrence of chronic illnesses that need radiological studies will boost this industry during this decade.

North America was the largest contributor to the industry in 2023, with a 45% share. This can be ascribed to the existence of highly developed healthcare infrastructure in this continent, as well as the increasing customer spending on healthcare. 

In addition, the U.S. was a significant contributor to the North American industry. This is because of the use of developed healthcare technologies in this country, coupled with the rising research activities in the continent.

With the rising application of these chemicals across different sectors, the imaging chemicals industry will continuously advance in the years to come.

Read More